China Pioneer Pharma Holdings Limited (1345.HK)
HKD 2.34
(-0.43%)
HKD 2.34
(-0.43%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -118.68 Million | 93.29 Million | 242.06 Million | 74.23 Million | 280.64 Million | 128.66 Million |
| Net Income | 180.44 Million | 235.29 Million | 142.63 Million | 52.44 Million | 104.62 Million | 84.59 Million |
| Depreciation & Amortization | 18.95 Million | 13.63 Million | 12.94 Million | 8.35 Million | 8.85 Million | 8.08 Million |
| Deferred income taxes | - | - | - | - | - | -385.24 Million |
| Stock-based compensation | - | - | - | - | - | -20 Thousand |
| Change in working capital | -237.84 Million | -193.49 Million | 226.31 Million | -147.34 Million | 4.84 Million | 385.26 Million |
| Other non-cash items | -516 Thousand | 37.86 Million | -139.83 Million | 160.78 Million | 162.31 Million | 35.98 Million |
| Investing Cash Flow | 69.5 Million | -12.99 Million | 8.39 Million | 23.92 Million | -82.64 Million | -198.62 Million |
| Investments in PPE | -44.55 Million | -74.27 Million | -16.63 Million | -34.87 Million | -8.88 Million | -385 Thousand |
| Acquisitions | 20.38 Million | -26.67 Million | -2.38 Million | -20.92 Million | 675 Thousand | -7.78 Million |
| Investment purchases | -113 Million | -717.2 Million | -2.02 Billion | -512.85 Million | -697.93 Million | -270.88 Million |
| Sales/Maturities of investments | 212.51 Million | 798.14 Million | 1.97 Billion | 570.48 Million | 542.41 Million | 50 Million |
| Other Investing Activities | -10.14 Million | 7 Million | 71.37 Million | 22.09 Million | 81.08 Million | 30.42 Million |
| Financing Cash Flow | -50.56 Million | -91.02 Million | -140.28 Million | -253.04 Million | -78.54 Million | -4.84 Million |
| Debt repayment | -31.11 Million | -1.09 Million | -42 Thousand | -83 Thousand | -4.68 Million | -61 Million |
| Dividends payments | -77.5 Million | -84.65 Million | -129.9 Million | -217.65 Million | - | - |
| Common Stock Repurchased | -22.72 Million | -25.77 Million | -10.33 Million | -2.79 Million | -19.43 Million | -74.9 Million |
| Common Stock Issuance | - | 26.87 Million | 10.37 Million | -2.79 Million | - | -1.87 Million |
| Other Financing Activities | 20.06 Million | -6.36 Million | -10.37 Million | -135.5 Million | -54.42 Million | 70.06 Million |
| Accounts receivables | 1.39 Million | -167.96 Million | 66.16 Million | -65.25 Million | -20.01 Million | 180.53 Million |
| Accounts payables | - | 1.85 Million | -6.93 Million | -7.05 Million | -14.61 Million | - |
| Inventory | -93 Million | -25.53 Million | 160.15 Million | -82.09 Million | 24.85 Million | 204.73 Million |
| Other working capital | -181 Thousand | -1.85 Million | 6.93 Million | 7.05 Million | 14.61 Million | 9.66 Million |
| Cash at beginning of period | 214 Million | 224.85 Million | 115 Million | 270.28 Million | 150.85 Million | 226.15 Million |
| Cash at end of period | 114.42 Million | 214 Million | 224.85 Million | 115 Million | 270.28 Million | 150.85 Million |
| Capital Expenditure | -44.55 Million | -74.27 Million | -16.63 Million | -34.87 Million | -8.88 Million | -385 Thousand |
| Effect of forex changes on cash | 160 Thousand | -120 Thousand | -335 Thousand | -401 Thousand | -24 Thousand | -495 Thousand |
| Net cash flow / Change in cash | -99.58 Million | -10.84 Million | 109.84 Million | -155.27 Million | 119.43 Million | -75.3 Million |
| Free Cash Flow | -163.24 Million | 19.02 Million | 225.42 Million | 39.36 Million | 271.75 Million | 128.28 Million |
| Breakdown | 2023 FY | 2023 Q4 | 2023 Q2 | 2022 FY | 2022 Q4 | 2022 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 180.44 Million | 68.71 Million | 77 Million | 235.29 Million | 113.07 Million | 122.21 Million |
| Depreciation & Amortization | 18.95 Million | 10.17 Million | 8.77 Million | 13.63 Million | 6.06 Million | 7.56 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -237.84 Million | -91.79 Million | - | -193.49 Million | -195.34 Million | - |
| Other non-cash items | -516 Thousand | 43.59 Million | -235.15 Million | 37.86 Million | 88.42 Million | -48.71 Million |
| Investing Cash Flow | 69.5 Million | 35.95 Million | 33.55 Million | -12.99 Million | 77.07 Million | -90.06 Million |
| Investments in PPE | -44.55 Million | -6.01 Million | -24.9 Million | -74.27 Million | -35.56 Million | -38.7 Million |
| Acquisitions | 20.38 Million | 19.75 Million | - | -26.67 Million | - | -25.96 Million |
| Investment purchases | -113 Million | - | - | -717.2 Million | - | - |
| Sales/Maturities of investments | 212.51 Million | - | - | 798.14 Million | - | - |
| Other Investing Activities | -10.14 Million | 22.21 Million | 58.46 Million | 7 Million | 112.64 Million | -25.39 Million |
| Financing Cash Flow | -50.56 Million | -42.91 Million | -7.64 Million | -91.02 Million | -67.76 Million | -23.25 Million |
| Debt repayment | -31.11 Million | - | -38 Thousand | -1.09 Million | - | -35 Thousand |
| Dividends payments | -77.5 Million | -26.04 Million | -51.45 Million | -84.65 Million | -19.36 Million | -65.29 Million |
| Common Stock Repurchased | -22.72 Million | -5.33 Million | -17.39 Million | -25.77 Million | -10.87 Million | -14.9 Million |
| Common Stock Issuance | - | - | 17.43 Million | 26.87 Million | - | 14.93 Million |
| Other Financing Activities | 20.06 Million | -11.53 Million | 61.23 Million | -6.36 Million | -37.52 Million | 56.97 Million |
| Accounts receivables | 1.39 Million | 1.39 Million | - | -167.96 Million | -167.96 Million | - |
| Accounts payables | - | - | - | 1.85 Million | - | - |
| Inventory | -93 Million | -93 Million | - | -25.53 Million | -25.53 Million | - |
| Other working capital | -181 Thousand | -181 Thousand | - | -1.85 Million | -1.85 Million | - |
| Cash at beginning of period | 214 Million | 90.83 Million | 214 Million | 224.85 Million | 193.05 Million | 224.85 Million |
| Cash at end of period | 114.42 Million | 114.42 Million | 90.83 Million | 214 Million | 214 Million | 193.05 Million |
| Capital Expenditure | -44.55 Million | -6.01 Million | -24.9 Million | -74.27 Million | -35.56 Million | -38.7 Million |
| Effect of forex changes on cash | 160 Thousand | -137 Thousand | 297 Thousand | -120 Thousand | -572 Thousand | 452 Thousand |
| Net cash flow / Change in cash | -99.58 Million | 23.59 Million | -123.17 Million | -10.84 Million | 20.95 Million | -31.79 Million |
| Free Cash Flow | -163.24 Million | 24.68 Million | -174.28 Million | 19.02 Million | -23.34 Million | 42.37 Million |
PRPO
DREAMFOLKS
CZMWF
URI
2169
DOTD